Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

Presentation AHA 2018

Ticagrelor vs Aspirin in Patients undergoing Coronary-Artery Bypass Grafting

Presenter: Heribert Schunkert

November 14, 2018

Presentation TCT Abstracts Posters 2018

IMPACT: Improving coronary graft Patency with postoperative Aspirin and Clopidogrel versus Aspirin and Ticagrelor

Presenter: Gerard Devlin

September 25, 2018

Presentation TCT Abstracts Posters 2018

A comparative study of one year all-cause mortality in ST Elevation myocardial infarction patients treated with prasugrel and ticagrelor after primary percutaneous coronary intervention

Presenter: Ayush Khurana

September 25, 2018

Presentation TCT 2018

HEALING-AMI: A Randomized Trial of Ticagrelor to Improve Left Ventricular Remodeling in ST-Segment Elevation Myocardial Infarction

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Yongwhi Park

September 24, 2018

Presentation TCT 2018

GLOBAL LEADERS: A Randomized Trial of Ticagrelor Monotherapy After PCI - Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Events

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Patrick W. Serruys

September 24, 2018

Presentation TCT 2018

GLOBAL LEADERS in Perspective: Perspectives on Ticagrelor Monotherapy

Presenter: Dominick J. Angiolillo, Elmir Omerovic, Patrick W. Serruys

September 23, 2018

Presentation TCT 2018

How Strong are the Pharmacodynamic Data and Clinical Evidence for Crushed Ticagrelor and Prasugrel?

Presenter: John A. Bittl, C. Michael Gibson, Dimitrios Alexopoulos

September 23, 2018

Advertisement

Ticagrelor vs Aspirin in Patients undergoing Coronary-Artery Bypass Grafting

IMPACT: Improving coronary graft Patency with postoperative Aspirin and Clopidogrel versus Aspirin and Ticagrelor

A comparative study of one year all-cause mortality in ST Elevation myocardial infarction patients treated with prasugrel and ticagrelor after primary percutaneous coronary intervention

HEALING-AMI: A Randomized Trial of Ticagrelor to Improve Left Ventricular Remodeling in ST-Segment Elevation Myocardial Infarction

GLOBAL LEADERS: A Randomized Trial of Ticagrelor Monotherapy After PCI - Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Events

GLOBAL LEADERS in Perspective: Perspectives on Ticagrelor Monotherapy

How Strong are the Pharmacodynamic Data and Clinical Evidence for Crushed Ticagrelor and Prasugrel?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content